Thanks Daniel and thanks for sharing your thoughts and the report. I for one was not aware of this. It basically increases the value of Race by 10x (maybe Grant Cardone will come sniffing...).
Most people do not like change, especially when their finances are involved unless it's interest rates decreasing. When it is left with a company and there are so many variables and unknowns, I think people would rather take their money and move onto the next shiny thing. But the way I see it, this greatly adds more value to shareholders and this process will wash out a lot who do not understand or who feel their returns will take longer, with those who see the bigger picture. Personally, I think the SP might go a little lower but within a couple of months we'll be in a completely different place.
Not only that, but if bisantrene continues to perform how it has in past studies, there will be a lot of happy patients and families whose lives / health have been greatly improved.
- Forums
- ASX - By Stock
- RAC
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-53
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.94 |
Change
0.000(0.00%) |
Mkt cap ! $330.4M |
Open | High | Low | Value | Volume |
$1.95 | $1.95 | $1.84 | $647.3K | 344.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | $1.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.94 | 5654 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 1.870 |
4 | 46789 | 1.840 |
2 | 6500 | 1.830 |
2 | 649 | 1.820 |
1 | 829 | 1.805 |
Price($) | Vol. | No. |
---|---|---|
1.940 | 5654 | 2 |
1.950 | 7570 | 1 |
1.960 | 1350 | 1 |
1.990 | 4701 | 2 |
1.995 | 10037 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online